Evolution to plasmablastic lymphoma evades CD19‐directed chimeric antigen receptor T cells

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 205-209

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD19 chimeric antigen receptor T cell therapy for haematological malignancies

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 463-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells

By Choi Yoonsu   Yuen Carrie   Maiti Sourindra   Olivares Simon   Gibbons Hillary   Huls Helen   Raphael Robert   Killian Thomas   Stark Daniel   Lee Dean   Torikai Hiroki   Monticello Daniel   Kelly Susan   Kebriaei Partow   Champlin Richard   Biswal Sibani   Cooper Laurence  

Biomedical Microdevices, Vol. 12, Iss. 5, 2010-10 ,pp. : 855-863

Springer Publishing Company

Access to resources Recommend Favorite

Chimeric antigen receptor T-cell neuropsychiatric toxicity in acute lymphoblastic leukemia

By  

Palliative & Supportive Care, Vol. 15, Iss. 4, 2017-01 ,pp. : 499-503

Cambridge University Press

Access to resources Recommend Favorite

Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 8, 2015-08 ,pp. : 1326-1336

John Wiley & Sons Inc

Access to resources Recommend Favorite